RegenX provides injectable treatment for the repair of damaged tendons and ligaments.
RegenX provides improvement in quality of life and a reduction in healthcare costs associated with tendon and ligament injuries, which are notoriously difficult and slow to heal. Their injectable repair system is proposed to reduce healing time and improve repair quality.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 14, 2020 | Grant | $255.94K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |